BPG is committed to discovery and dissemination of knowledge
Review
Copyright ©The Author(s) 2025.
World J Diabetes. Oct 15, 2025; 16(10): 111309
Published online Oct 15, 2025. doi: 10.4239/wjd.v16.i10.111309
Table 1 Risk factors for gestational diabetes mellitus
Risk factors
Overweight or obese adults (BMI ≥ 25 kg/m2, ≥ 23 kg/m2 for Asians) with at least one of the following risk factors:
    History of diabetes in a first-degree relative
    High-risk race or ethnicity (e.g., African American, Latin American)
    History of cardiovascular disease
    HDL cholesterol level < 35 mg/dL (< 0.9 mmol/L) and/or triglyceride level > 250 mg/dL (> 2.8 mmol/L)
    Polycystic ovary syndrome
    Physical inactivity
    Other clinical conditions associated with insulin resistance (obesity, acanthosis nigricans)
Prediabetes (HbA1c ≥ 5.7%) and impaired fasting and glucose tolerance
Individuals previously diagnosed with GDM
Individuals afflicted with HIV, those utilizing medications that elevate the risk of diabetes, and those with a history of pancreatitis. Additionally, ACOG:
    History of birth over 4000 g
    Hypertension (140/90 mmHg or those taking antihypertensive medication)
Table 2 Maternal and fetal complications of gestational diabetes mellitus

Maternal
Fetal
Short termPreeclampsiaMacrosomia
Preterm deliveryShoulder dystocia
Caesarean sectionPerinatal mortality
Failure to progress in labour and instrumental deliveryAdmission to NICU
Neonatal hypoglycaemia
Hyperbilirubinaemia
Long termRecurrent GDM in subsequent pregnanciesType 2 diabetes
Type 2 diabetesObesity
Cardiovascular disease
Table 3 Screening and diagnosis of gestational diabetes mellitus

One-step strategy
Two-step strategy
Test75 g OGTT: In individuals without a prior diagnosis of diabetes, screening is performed in the fasting state between 24 and 28 weeks of gestation (following a minimum of 8 hours of overnight fasting). GDM is diagnosed if any of the following blood glucose thresholds are met or exceededFirst step: 50 g glucose challenge test: This test is administered between 24 and 28 weeks of gestation in individuals without a prior diagnosis of diabetes and does not require fasting. If the 1-hour plasma glucose level meets or exceeds the specified threshold values, a 100 g OGTT should be performed
Blood glucose thresholdsIADPSG: Fasting glucose ≥ 93 mg/dL (≥ 5.1 mmol/L)Fasting glucose ≥ 95 mg/dL (≥ 5.3 mmol/L)
1-hour plasma glucose ≥ 180 mg/dL (≥ 10.0 mmol/L)1-hour plasma glucose ≥ 180 mg/dL (≥ 10.0 mmol/L)
2-hour plasma glucose ≥ 153 mg/dL (≥ 8.5 mmol/L)2-hour plasma glucose ≥ 155 mg/dL (≥ 8.6 mmol/L)
Carpenter-Coustan criteria: Fasting glucose ≥ 95 mg/dL (≥ 5.3 mmol/L)2-hour plasma glucose ≥ 140 mg/dL (≥ 7.8 mmol/L)
1-hour plasma glucose ≥ 180 mg/dL (≥ 10.0 mmol/L)
2-hour plasma glucose ≥ 155 mg/dL (≥ 8.6 mmol/L)
Table 4 Gestational diabetes mellitus screening strategies recommended by various international organizations
Guide
Strategy
ADA75 g OGTT for all pregnant women
ACOGAdminister a 50 g GCT for all pregnant women; a 100 g OGTT is required if the initial test is positive
WHO75 g OGTT for all pregnant women
NICE75 g OGTT risk-based approach
FIGO75 g OGTT for all pregnant women